Corteva, Inc. (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals. The company markets improved seed varieties for major row crops, invests in breeding and biotechnology to enhance yield and resilience, and offers precision‑agriculture and digital platforms designed to optimize input use and agronomic decisions. Corteva also works with channel partners to supply seed, crop protection products and advisory services to growers.
Corteva is headquartered in the United States and operates on a global scale, serving farmers and distributors across the Americas, Europe, Asia and other agricultural regions. The company emphasizes ongoing R&D investment, product stewardship and collaboration with growers, industry partners and academic institutions to advance sustainable productivity. Information on specific executive leadership is not provided here to avoid inaccuracy; investors should consult company filings or the corporate website for up‑to‑date leadership details.